Featured Research

from universities, journals, and other organizations

Five-Week Antibiotic Treatment May Improve Cardiovascular Function

Date:
March 4, 2002
Source:
American Heart Association
Summary:
For the first time researchers have shown that an antibiotic improved vascular function in people with angina who tested positive for Chlamydia pneumoniae in their blood. The research is reported in the rapid access issue of Circulation: Journal of the American Heart Association.

DALLAS, Feb. 26 – For the first time researchers have shown that an antibiotic improved vascular function in people with angina who tested positive for Chlamydia pneumoniae in their blood. The research is reported in today’s rapid access issue of Circulation: Journal of the American Heart Association.

Related Articles


Coronary artery disease patients who tested positive for C. pneumoniae showed improved blood flow in the brachial artery (in the arm) and reduced blood levels of two known markers for endothelial dysfunction after five weeks of daily treatment with azithromycin. Patients given placebo did not improve.

Damage to the endothelium, the delicate lining inside arteries and other blood vessels, may lead to atherosclerotic plaques forming and eventually to chest pain (angina) and heart attacks. For several years heart researchers have tried to identify a specific bacterium or virus that might damage the endothelium. Once a microbe was identified, researchers tried to find an antibiotic that could eradicate it, says Juan Carlos Kaski, M.D., a co-author of the study and a professor of cardiovascular science at St. George’s Hospital Medical School, London. He says that C. pneumoniae proved to be a good candidate for this approach because it is a common infection and evidence of it has been discovered in plaque removed from arteries of people with coronary artery disease.

“We have found in this study that treatment with azithromycin, an antibiotic used to treat C. pneumoniae infections, improved the function of the endothelium,” says Kaski. “The antibiotic thus appears to allow the artery to increase its caliber.” This caliber change means the vessel widens in response to appropriate stimuli. Forty males, average age 55, were enrolled in the study. All had documented coronary artery disease. They were randomly assigned to receive either azithromycin or placebo for five weeks. Flow-mediated dilation (FMD) of the brachial artery was measured at study entry and at the end of treatment. FMD measures the blood vessel’s ability to relax in response to blood flow increases, and also endothelial function. A healthy artery (with a healthy endothelium) will be more “flexible” than a diseased artery. In addition, levels of E-selectin and von Willebrand factor (both markers of endothelial dysfunction) and levels of C-reactive protein (a marker of inflammation) were measured at entry and after treatment.

After treatment, patients’ average FMD of the brachial artery improved from 2.66 percent at baseline to 4.78 percent. In the placebo group the baseline measurement was 3.11 percent and at five weeks it was 3.09 percent, indicating no improvement. Moreover, in treated patients, the level of E-selectin declined by an average of 28.2 nanograms per milliliter (ng/mL) in treated patients and von Willebrand factor level declined by an average of 36.6 International Units per deciliter (IU/dL).

The study showed improved arterial function, but it was not designed to provide evidence that the antibiotic could reverse atherosclerosis or reduce the number of heart attacks. Moreover, Kaski says the benefit of the antibiotic might not be a direct result of the drug’s ability to eradicate the pathogen, because their study showed that patients who had very high levels of C. pneumoniae antibodies had essentially the same benefit as those with low levels.

A direct anti-inflammatory action of the antibiotic has been suggested because azithromycin is in a class of drugs called macrolides, which have anti-inflammatory effects. Inflammation is one of the body’s responses to infection. But Kaski says that the question remains open since azithromycin did not reduce the levels of C-reactive protein in this study.

“Thus whether the beneficial effects of azithromycin were due to its antibacterial or anti-inflammatory actions is unresolved by our study,” says Kaski.

The next step, he says, is to design a study that will allow the researchers to “identify the mechanism responsible for the beneficial effect of antibiotics so that we arrive at a rational treatment, which might include developing even more effective antibiotics or perhaps a vaccine, or just appropriate anti-inflammatory agents.” However, it is too soon to recommend the use of antibiotics to either treat or prevent heart disease.

Kaski’s co-authors were Nikhil Parchure, MRCP, and Emmanouil G. Zouridakis, M.D.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Cite This Page:

American Heart Association. "Five-Week Antibiotic Treatment May Improve Cardiovascular Function." ScienceDaily. ScienceDaily, 4 March 2002. <www.sciencedaily.com/releases/2002/02/020226075248.htm>.
American Heart Association. (2002, March 4). Five-Week Antibiotic Treatment May Improve Cardiovascular Function. ScienceDaily. Retrieved November 29, 2014 from www.sciencedaily.com/releases/2002/02/020226075248.htm
American Heart Association. "Five-Week Antibiotic Treatment May Improve Cardiovascular Function." ScienceDaily. www.sciencedaily.com/releases/2002/02/020226075248.htm (accessed November 29, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, November 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
WHO Says Male Ebola Survivors Should Abstain From Sex

WHO Says Male Ebola Survivors Should Abstain From Sex

Newsy (Nov. 28, 2014) — WHO cites four studies that say Ebola can still be detected in semen up to 82 days after the onset of symptoms. Video provided by Newsy
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins